Active immunotherapy for lung cancer. Systematic review.

Moza-Moríñigo H, Llanos-Méndez A, Baños-Álvarez E, Isabel-Gómez R.
Record ID 32018000427
Spanish
Original Title: Inmunoterapia activa para el cáncer de pulmón. Revisión sistemática.
Authors' objectives: To know the effectiveness in terms of survival and time to progression and safety of active immunotherapy against lung cancer in advanced stages.
Authors' results and conclusions: Overall survival time showed no significantly increased in patients in the experimental group. Progression-free survival time only showed statistical differences in one study. The short follow-up may explain this outcomes, since the life expectancy is limited in patients with an advanced cancer stage.
Details
Project Status: Completed
Year Published: 2015
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: Spain
MeSH Terms
  • Lung Neoplasms
  • Cancer Vaccines
  • Immunotherapy
  • Immunotherapy, Active
  • Therapeutics
Keywords
  • Cáncer de pulmón
  • Inmunología
  • Vacunas contra el cáncer
Contact
Organisation Name: Andalusian Health Technology Assessment Area
Contact Address: Area de Evaluacion de Tecnologias Sanitarias Sanitarias de Andalucia (AETSA) Avda. Innovación, s/n Edificio Arena 1. Sevilla (Spain) Tel. +34 955 006 309
Contact Name: aetsa.csalud@juntadeandalucia.es
Contact Email: aetsa.csalud@juntadeandalucia.es
Copyright: Andalusian Health Technology Assessment Area (AETSA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.